Understanding New WHO Classification of MPNs

The 2016 multiparameter WHO (World Health Organization) classification for Philadelphia-negative myeloproliferative neoplasms (MPNs) integrates clinical features, morphology and genetic data to diagnose polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF), now subgrouped into prefibrotic PMF and overt PMF.1

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Francesco Passamonti, Barbara Mora, Margherita Maffioli Source Type: research